Literature DB >> 33058306

What causes hidradenitis suppurativa ?-15 years after.

Christos C Zouboulis1,2, Farida Benhadou1,3, Angel S Byrd4, Nisha S Chandran1,5, Evangelos J Giamarellos-Bourboulis1,6, Gabriella Fabbrocini1,7, John W Frew8, Hideki Fujita9, Marcos A González-López1,10, Philippe Guillem1,11, Wayne P F Gulliver1,12, Iltefat Hamzavi13, Yildiz Hayran14, Barbara Hórvath1,15, Sophie Hüe16, Robert E Hunger1,17, John R Ingram1,18, Gregor B E Jemec1,19, Qiang Ju1,20, Alexa B Kimball21, Joslyn S Kirby22, Maria P Konstantinou23, Michelle A Lowes8, Amanda S MacLeod24, Antonio Martorell1,25, Angelo V Marzano1,26,27, Łukasz Matusiak1,28, Aude Nassif1,29, Elena Nikiphorou30, Georgios Nikolakis1,2, André Nogueira da Costa1,31, Martin M Okun32, Lauren A V Orenstein33, José Carlos Pascual1,34, Ralf Paus1,35, Benjamin Perin36, Errol P Prens1,37, Till A Röhn38, Andrea Szegedi39, Jacek C Szepietowski1,28, Thrasyvoulos Tzellos1,40, Baoxi Wang1,41, Hessel H van der Zee1,37.   

Abstract

The 14 authors of the first review article on hidradenitis suppurativa (HS) pathogenesis published 2008 in EXPERIMENTAL DERMATOLOGY cumulating from the 1st International Hidradenitis Suppurativa Research Symposium held March 30-April 2, 2006 in Dessau, Germany with 33 participants were prophetic when they wrote "Hopefully, this heralds a welcome new tradition: to get to the molecular heart of HS pathogenesis, which can only be achieved by a renaissance of solid basic HS research, as the key to developing more effective HS therapy." (Kurzen et al. What causes hidradenitis suppurativa? Exp Dermatol 2008;17:455). Fifteen years later, there is no doubt that the desired renaissance of solid basic HS research is progressing with rapid steps and that HS has developed deep roots among inflammatory diseases in Dermatology and beyond, recognized as "the only inflammatory skin disease than can be healed". This anniversary article of 43 research-performing authors from all around the globe in the official journal of the European Hidradenitis Suppurativa Foundation e.V. (EHSF e.V.) and the Hidradenitis Suppurativa Foundation, Inc (HSF USA) summarizes the evidence of the intense HS clinical and experimental research during the last 15 years in all aspects of the disease and provides information of the developments to come in the near future.
© 2020 The Authors. Experimental Dermatology published by John Wiley & Sons Ltd.

Entities:  

Keywords:  acne inversa; hair follicle; hidradenitis suppurativa; inflammatory skin diseases; pathogenesis

Year:  2020        PMID: 33058306     DOI: 10.1111/exd.14214

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  17 in total

1.  Holistic health record for Hidradenitis suppurativa patients.

Authors:  Paola Maura Tricarico; Chiara Moltrasio; Anton Gradišek; Angelo V Marzano; Vincent Flacher; Wacym Boufenghour; Esther von Stebut; Matthias Schmuth; Wolfram Jaschke; Matjaž Gams; Michele Boniotto; Sergio Crovella
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

2.  Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa - A New Syndromic Form of HS? A Report of Two Cases.

Authors:  Philippe Guillem; Dillon Mintoff; Mariam Kabbani; Elie Cogan; Virginie Vlaeminck-Guillem; Agnes Duquesne; Farida Benhadou
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 3.  Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling.

Authors:  Mahendra Pratap Kashyap; Jasim Khan; Rajesh Sinha; Lin Jin; Venkatram Atigadda; Jessy S Deshane; Ayesha R Ahmed; Ali Kilic; Chander Raman; M Shahid Mukhtar; Craig A Elmets; Mohammad Athar
Journal:  Semin Cell Dev Biol       Date:  2022-02-04       Impact factor: 7.499

Review 4.  [Pathogenesis of hidradenitis suppurativa/acne inversa].

Authors:  G Nikolakis; G Kokolakis; K Kaleta; K Wolk; R Hunger; R Sabat; C C Zouboulis
Journal:  Hautarzt       Date:  2021-07-06       Impact factor: 0.751

5.  Autoantibodies Present in Hidradenitis Suppurativa Correlate with Disease Severity and Promote the Release of Proinflammatory Cytokines in Macrophages.

Authors:  Carmelo Carmona-Rivera; Liam J O'Neil; Eduardo Patino-Martinez; William D Shipman; Chengsong Zhu; Quan-Zhen Li; Michelle L Kerns; Leandra A Barnes; Julie A Caffrey; Sewon Kang; Mariana J Kaplan; Ginette A Okoye; Angel S Byrd
Journal:  J Invest Dermatol       Date:  2021-10-01       Impact factor: 8.551

Review 6.  Aquaporins Are One of the Critical Factors in the Disruption of the Skin Barrier in Inflammatory Skin Diseases.

Authors:  Paola Maura Tricarico; Donatella Mentino; Aurora De Marco; Cecilia Del Vecchio; Sabino Garra; Gerardo Cazzato; Caterina Foti; Sergio Crovella; Giuseppe Calamita
Journal:  Int J Mol Sci       Date:  2022-04-05       Impact factor: 5.923

Review 7.  [Clinical, pathology-associated and molecular biomarkers of hidradenitis suppurativa/acne inversa].

Authors:  M von Laffert; R E Hunger; A A Navarini; C C Zouboulis
Journal:  Hautarzt       Date:  2021-07-02       Impact factor: 0.751

Review 8.  Quality of Life in Hidradenitis Suppurativa: An Update.

Authors:  Pavel V Chernyshov; Andrew Y Finlay; Lucia Tomas-Aragones; Francoise Poot; Francesca Sampogna; Servando E Marron; Sergey V Zemskov; Damiano Abeni; Thrasyvoulos Tzellos; Jacek C Szepietowski; Christos C Zouboulis
Journal:  Int J Environ Res Public Health       Date:  2021-06-06       Impact factor: 3.390

9.  Anti-COVID-19 measurements for hidradenitis suppurativa patients.

Authors:  Evangelos J Giamarellos-Bourboulis; Vincenzo Bettoli; Gregor B E Jemec; Veronique Del Marmol; Angelo V Marzano; Errol P Prens; Thrasyvoulos Tzellos; Christos C Zouboulis
Journal:  Exp Dermatol       Date:  2021-06       Impact factor: 3.960

Review 10.  Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis.

Authors:  Viktor A Zouboulis; Konstantin C Zouboulis; Christos C Zouboulis
Journal:  Pharmaceutics       Date:  2021-12-26       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.